Clinical applications of iontophoretic devices in rehabilitation medicine

Critical Reviews in Physical and Rehabilitation Medicine

Volumn 10, Issue 2, 1998, Pages 147-179

  Banga, Ajay K ^a   Panus, Peter C ^b  

^a AUBURN UNIVERSITY   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Cutaneous administration; Drug delivery systems; Iontophoresis; Phonophoresis

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; DICLOFENAC; GLUCOCORTICOID; KETOPROFEN; KETOROLAC; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PIRPROFEN;

CANNULATION; CAUTERIZATION; DEVICE; DRUG DELIVERY SYSTEM; DRUG RESEARCH; ELECTRODE; HUMAN; IONTOPHORESIS; PH; PRIORITY JOURNAL; REVIEW; SKIN; SKIN ABSORPTION; SKIN APPENDAGE; TRANSDERMAL DRUG ADMINISTRATION; VEIN PUNCTURE;

EID: 0031731712     PISSN: 08962960     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevPhysRehabilMed.v10.i2.30     Document Type: Review

References (178)

1. Brown, L. and Langer, R., Transdermal delivery of drugs., Ann. Rev. Med., 39, 221-229, 1988.
2. Ranade, V. V., Drug delivery systems. VI. Transdermal drug delivery, J. Clin. Pharmacol., 31, 401-418, 1991.
3. Guy, R. H., Current status and future prospects of transdermal drug delivery, Pharm. Res., 13(12), 1765-1769, 1996.
4. Berti, J. J. and Lipsky, J. J., Transcutaneous drug delivery: a practical review, Mayo Clin. Proc., 70, 581-586, 1995.
5. Morley, S. M., Keratin and the skin: past, present, and future, Q. J. Med., 90, 433-435, 1997.
6. Fartasch, M., The nature of the epidermal barrier: structural aspects, Adv. Drug Del. Rev., 18, 273-282, 1996.
7. Denda, M., Koyama, J., Namba, R., and Horii, I., Stratum-corneum lipid morphology and transepidermal water loss in normal skin and surfactant-induced scaly skin, Arch. Dermatol Res., 286, 41-46, 1994.
8. Melski, J. W., The anatomy and physiology of the skin, in Principles and Practice of Skin Excisions, Jemec, B. I. E. and Jemec, G. B. E., Eds., Elsevier, Amsterdam, Netherlands, 1996, 1-14.
9. Steinstrasser, I. and Merkle, H. P., Dermal metabolism of topically applied drugs: pathways and models reconsidered., Pharm. Acta Helv., 70(1), 3-24, 1995.
10. Banga, A. K. and Chien, Y. W., Iontophoretic delivery of drugs: fundamentals, developments, and biomedical applications, J. Controlled Rel., 17, 1-24, 1988.
11. Pikal, M. J., Penetration enhancement of peptide and protein drugs by electrochemical means: transdermal iontophoresis, in Trends and Future Perspectives in Peptide and Protein Drug Delivery, Lee, V. H. L., Hashida, M., and Mizushima, Y., Eds., Harwood Academic Publishers GmbH, Chur, Switzerland, 1995, 83-109.
12. Inamori, T., Ghanem, A. H., Higuchi, W. I., and Srinivasan, V., Macromolecule transport in and effective pore size of ethanol pretreated human epidermal membrane, Int. J. Pharm., 105, 113-123, 1994.
13. Aguilella, V., Kontturi, K., Murtomaki, L., and Ramirez, P., Estimation of the pore size and charge density in human cadaver skin, J. Control. Release, 32, 249-257, 1994.
14. Boss, J. D., Skin Immune System: Cutaneous Immunology and Clinical Immunodermatology, CRC Press, Boca Raton, FL, 1997.
15. Howes, D., Hadgraft, J., Heylings, J., Hoeck, U., Kemper, F., Maibach, H., Marty, J. P., Merk, H., Parra, J., Rekkas, D., Rondelli, I. S. H., Tauber, U., and Verbiese N., Methods for assessing percutaneous absorption - the report and recommendations of ECVAM workshop 13. ATLA. Altern. Lab. Anim., 24, 81-106, 1996.
16. Yamamoto, T. and Yamamoto, Y., Electrical properties of the epidermal stratum corneum, Med. Biol. Eng., 14, 151-158, 1976.
17. Lin, R. Y., Ou, Y. C., and Chen, W. Y., The role of electroosmotic flow on in vitro transdermal iontophoresis, J. Control. Release, 43, 23-33, 1997.
18. Emtestam, L. and Ollmar, S., Electrical impedance index in human skin: measurements after occlusion, in 5 anatomical regions and in mild irritant contact dermatitis, Contact Dermatitis, 28, 104-108, 1993.
19. Pliquett, F. and Pliquett, U., Passive electrical properties of human stratum corneum in vitro depending on time after separation, Biophys. Chem., 58, 205-210, 1996.
20. Plutchik, R. and Hirsch, H. R., Skin impedance and phase angle as a function of frequency and current, Science, 141, 927-928, 1963.
21. Boxtel, A. V., Skin resistance during square-wave electrical pulses of 1 to 10 mA, Med. Biol. Eng. Comput., 15, 679-687, 1977.
22. Calderwood, J. H., Electrode-skin impedance from a dielectric viewpoint, Physiol. Meas., 17, AU31-AU39, 1996.
23. Kalia, Y. N. and Guy, R. H., The electrical characteristics of human skin in vivo, Pharm. Res., 12(11), 1605-1613, 1995.
24. + permeability of excised nude mouse skin, J. Pharm. Sci., 77(6), 492-497, 1988.
25. Burnette, R. R. and Ongpipattanakul, B., Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis, J. Pharm. Sci., 77(2), 132-137, 1988.
26. Stephens, W. G. S., The current-voltage relationship in human skin, Med. Electron. Biol. Eng., 1, 389-399, 1963.
27. Kasting, G. B. and Bowman, L. A., Electrical analysis of fresh, excised human skin: a comparison with frozen skin, Pharm. Res., 7, 1141-1146, 1990.
28. Kasting, G. B. and Bowman, L. A., DC electrical properties of frozen, excised human skin, Pharm. Res., 7, 134-143, 1990.
29. Ruddy, S. B. and Hadzija, B. W., The role of stratum corneum in electrically facilitated transdermal drug delivery . I. Influence of hydration, tape-stripping and delipidization on the DC electrical properties of skin, J. Control. Release, 37, 225-238, 1995.
30. Oh, S. Y., Leung, L., Bommannan, D., Guy, R. H., and Potts, R. O., Effect of current, ionic strength and temperature on the electrical properties of skin, J. Control. Release, 27, 115-125, 1993.
31. Michaels, A. S., Chandrasekaran, S. K., and Shaw, J. E., Drug permeation through human skin: theory and in vitro experimental measurement, AICHE J., 21, 985-996, 1975.
32. Elias, P. M., Epidermal lipids, barrier function, and desquamation, J. Invest. Dermatol., 80, 44s-49s, 1983.
33. Elias, P. M., Structure and function of the stratum corneum permeability barrier, Drug Dev. Res., 13, 97-105, 1988.
34. Tojo, K., Random brick model for drug transport across stratum corneum., J. Pharm. Sci., 76(12), 889-891, 1987.
35. Potts, R. O. and Guy, R. H., Predicting skin permeability, Pharm. Res., 9, 663-669, 1992.
36. Pugh, W. J. and Hadgraft, J., Ab initio prediction of human skin permeability coefficients, Int. J. Pharm., 103, 163-178, 1994.
37. Lee, A. J., King, J. R., and Barrett, D. A., Percutaneous absorption: a multiple pathway model, J. Control. Release., 45(2), 141-151, 1997.
38. Kirchner, L. A., Moody, R. P., Doyle, E., Bose, R., Jeffery, J., and Chu, I., The prediction of skin permeability by using physicochemical data, ATLA, 25(3), 359-370, 1997.
39. Hisoire, G. and Bucks, D., An unexpected finding in percutaneous absorption observed between haired and hairless guinea pig skin, J. Pharm. Sci., 86(3), 398-400, 1997.
40. Riviere, J. E. and Heit, M. C., Electrically-assisted transdermal drug delivery, Pharm. Res., 14(6), 687-697, 1997.
41. Singh, J. and Roberts, M. S., Transdermal delivery of drugs by iontophoresis: a review, Drug Des. Delivery, 4(1), 1-12, 1989.
42. Kim, A., Green, P. G., Rao, G., and Guy, R. H., Convective solvent flow across the skin during iontophoresis., Pharm. Res., 10(9), 1315-1320, 1993.
43. Singh, P. and Maibach, H. I., Transdermal iontophoresis. Pharmacokinetic considerations, Clin. Pharmacokinet., 26(5), 327-34, 1994.
44. Singh, J. and Bhatia, K. S., Topical iontophoretic drug delivery: pathways, principles, factors, and skin irritation, Med. Res. Rev., 16(3), 285-296, 1996.
45. Green, P., Iontophoretic transdermal drug delivery: a new commercially feasible technology, Hotel International, Basel, Switzerland, October 17-18 (Organized by A. K. Banga and P. Green through Technomic Publishing), 1996.
46. Chien, Y. W. and Banga, A. K., Iontophoretic (transdermal) delivery of drugs: overview of historical development, J. Pharm. Sci., 78(5), 353-354, 1989.
47. Gibson, L. E. and Cooke, R. E., A test for the concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis, Pediatrics, 23, 545-549, 1959.
48. Abramson, H. A. and Gorin, M. H., Skin reactions. IX. The electrophoretic demonstration of the patent pores of the living human skin; its relation to the charge of the skin, J. Phys. Chem., 44, 1094-1102, 1940.
49. Hinsberg, W. H. M. C., Verhoef, J. C., Bax, L. J., Junginger, H. E., and Bodde, H. E., Role of appendages in skin resistance and iontophoretic peptide flux: human vs. snake skin, Pharm. Res., 12, 1506-1512, 1995.
50. Singh, P., Anliker, M., Smith, G. A., Zavortink, D., and Maibach, H. I., Transdermal iontophoresis and solute penetration across excised human skin, J. Pharm. Sci., 84(11), 1342-1346, 1995.
51. Cullander, C., What are the pathways of iontophoretic current flow through mammalian skin? Adv. Drug Del. Rev., 9, 119-135, 1992.
52. Finkelstein, A. and Mauro, A., Physical Principles and Formalisms of Electrical Excitability, in Handbook of Physiol. Am. Phys. Soc., Bethesda, MD, 1977, 161-213.
53. Gwynne, P., Companies developing more uses for iontophoresis, The Scientist, 11(20), 1, 1997.
54. Maurer, D. D., Williams, T. J., and Stevens, S. A., Multiple Site Drug Iontophoresis Electronic Device and Method, Assignee Empi, MN, U.S.A. Patent 5,254,081, 1993.
55. Tapper, R., Iontophoretic Treatment System, Assignee Tapper, R., U.S.A. Patent 5,224,927, 1993.
56. Sage, B. H., Iontophoresis, in Encyclopedia of Pharmaceutical Technology, Swarbrick, J. and Boylan, J. C., Eds., Marcel Dekker, Inc., NY, 1993, 217-247.
57. Sanderson, J. E. and Deriel, S. R., Methods and Apparatus for Iontophoretic Drug Delivery, FL, U.S.A. Patent 4,722,726, 1988.
58. Sanderson, J. E., de Riel, S., and Dixon, R., Iontophoretic delivery of nonpeptide drugs: formulation optimization for maximum skin permeability, J. Pharm. Sci., 78(5), 361-364, 1989.
59. Petelenz, T. J., Jacobsen, S. C., Stephen, R. L., and Janata, J., Methods and Apparatus for Iontophoresis Applications of Medicaments at a Controlled PH Through Ion Exchange, UT, U.S.A. Patent 4,915,685, 1990.
60. Johnson, M. T. V. and Lee, N. H., PH Buffered Electrodes for Medical Iontophoresis, Assignee Empi, MN, U.S.A. Patent 4,973,303, 1990.
61. Cullander, C., Rao, G., and Guy, R. H., Why silver/silver chloride? in Criteria for Iontophoresis Electrodes, Brain, K. R., James, V. J., and Walters, K. A., Eds., STS Publishing, Cardiff, Wales, 1993, 381-390.
62. Howard, J. P., Drake, T. R., Dean, B. S., and Kellog, D. L., Effects of Alternating current iontophoresis on drug delivery, Arch. Phys. Med. Rehabil., 76, 463-466, 1995.
63. Powers, W. R. and Sisun, H., Electrodes, Electrode Assemblies, Methods, and Systems for Tissue Stimulation and Transdermal Delivery of Pharmacologically Active Ligands, Assignee Boston Univ., Boston, MA, U.S.A. Patent 4,702,732, 1987.
64. Powers, W. R. and Sisun, H., Electrodes, Electrode Assemblies, Methods, and Systems for Tissue Stimulation, Assignee Boston Univ., Boston, MA, U.S.A. Patent 4,786,277, 1988.
65. D'Emanuele, A. and Staniforth, J. N., An electrically modulated drug delivery device: I., Pharm. Res., 8(7), 913-918, 1991.
66. D'Emanuele, A. and Staniforth, J. N., An electrically modulated drug delivery device. II. Effect of ionic strength, drug concentration, and temperature, Pharm. Res., 9(2), 215-219, 1992.
67. D'Emanuele, A. and Staniforth, J. N., An electrically modulated drug delivery device. III. Factors affecting drug stability during electrophoresis, Pharm. Res., 9, 312-315, 1992.
68. Banga, A. K. and Chien, Y. W., Dermal absorption of peptides and proteins, in Pharmaceutical Biotechnology. Vol. 4. Biological Barriers to Protein Delivery, Audus, K. L. and Raub, T. J., Eds., Plenum Press, New York, NY, 1993, 179-197.
69. Lelawongs P., Liu, J., Siddiqui, O., and Chien, Y. W., Transdermal iontophoretic delivery of argininevasopressin (I): Physicochemical considerations, Int. J. Pharm., 56, 13-22, 1989.
70. Brand, R. M., Duensing, G., and Hamel, F. G., Iontophoretic delivery of an insulin-mimetic peroxovanadium compound, Int. J. Pharm., 146(1), 115-122, 1997.
71. Hollinger, M. A., Toxicological aspects of topical silver pharmaceuticals, Crit. Rev. Toxicol., 26(3), 255-260, 1996.
72. Phipps, J. B., Padmanabhan, R. V., and Lattin, G. A., Iontophoretic delivery of model inorganic and drug ions, J. Pharm. Sci., 78(5), 365-269, 1989.
73. Yoshida, N. H. and Roberts, M. S., Structure-transport relationships in transdermal iontophoresis, Adv. Drug Del. Rev., 9, 239-264, 1992.
74. Gangarosa, L. P., Park, N. H., Fong, B. C., Scott, D. F., and Hill, J. M., Conductivity of drugs used for iontophoresis, J. Pharm. Sci., 67(10), 1439-1443, 1978.
75. Lattin, G. A., Padmanabhan, R. V., and Phipps, J. B., Electronic control of iontophoretic drug delivery, Ann. N. Y. Acad. Sci., 618, 450-464, 1991.
76. Yoshida, N. H. and Roberts, M. S., Role of conductivity in iontophoresis. II. Anodal iontophoretic transport of phenylethylamine and sodium across excised human skin, J. Pharm. Sci., 83(3), 344-350, 1994.
77. Yoshida, N. H. and Roberts, M. S., Prediction of cathodal iontophoretic transport of various anions across excised skin from different vehicles using conductivity measurements, J. Pharm. Pharmacol., 47, 883-890, 1995.
78. Miller, L. L. and Smith, G. A., Iontophoretic transport of acetate and carboxylate ions through hairless mouse skin. A cation exchange membrane model, Int. J. Pharm., 49, 15-22, 1989.
79. Thysman, S., Preat, V., and Roland, M., Factors affecting iontophoretic mobility of metoprolol, J. Pharm. Sci., 81(7), 670-675, 1992.
80. Chu, D. L., Chiou, H. J., and Wang, D. P., Characterization of transdermal delivery of nefopam hydrochloride under iontophoresis, Drug Dev. Ind. Pharm., 20, 2775-2785, 1994.
81. Cullander, C. and Guy, R. H., (D) Routes of delivery: Case studies (6) Transdermal delivery of peptides and proteins, Adv. Drug Del. Rev., 8, 291-329, 1992.
82. Gangarosa, L. P., Park, N., Wiggins, C. A., and Hill, J. M., Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (Iontohydrokinesis), J. Pharmacol. Exp. Therp., 212, 377-381, 1980.
83. Pikal, M. J., The role of electroosmotic flow in transdermal iontophoresis, Adv. Drug Del. Rev., 9, 201-237, 1992.
84. Burnette, R. R. and Ongpipattanakul, B., Characterization of the permselective properties of excised human skin during iontophoresis, J. Pharm. Sci., 76, 765-773, 1987.
85. Pikal, M. J. and Shah, S., Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes, Pharm. Res., 7, 222-229, 1990.
86. Pikal, M. J., Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis, Pharm. Res., 7(2), 118-126, 1990.
87. Kari, B., Control of blood glucose levels in alloxandiabetic rabbits by iontophoresis of insulin, Diabetes, 35(2), 217-221, 1986.
88. Erlanger, G., Iontophoresis, a scientific and practical tool in ophthalmology, Ophthalmologica, 128, 232-245, 1954.
89. Barza, M., Peckman, C., and Baum, J., Transscleral iontophoresis of gentamicin in monkeys, Invest. Ophthalmol. Vis. Sci., 28(6), 1033-1036, 1987.
90. Barza, M., Peckman, C., and Baum, J., Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit, Ophthalmology, 93(1), 133-139, 1986.
91. Maurice, D. M., Iontophoresis of fluorescein into the posterior segment of the rabbit eye, Ophthalmology, 93(1), 128-132, 1986.
92. Hill, J. M., O'Callaghan, R. J., and Hobden, J. A., Ocular Iontophoresis, in Ophthalmic Drug Delivery Systems, Mitra, A. K., Ed., Marcel Dekker, Inc., NY, 1993, 331-354.
93. Sarraf, D. and Lee, D. A., The role of iontophoresis in ocular drug delivery, J. Ocul. Pharmacol., 10(1), 69-81, 1994.
94. Brough, K. M., Anderson, D. M., Love, J., and Overman, P. R., The effectiveness of iontophoresis in reducing dentin hypersensitivity, J. Am. Dent. Assoc., 111(5), 761-765, 1985.
95. Gangarosa, L. P., Sr., Fluoride iontophoresis for tooth desensitization [letter], J. Am. Dent. Assoc., 112(6), 808-810, 1986.
96. Labhasetwar, V. and Levy, R. J., Novel delivery of antiarrhythmic agents, Clin. Pharmacokinet., 29(1), 1-5, 1995.
97. Avitall, B., Myocardial Iontophoresis, Assignee Avitall, B., WI, U.S.A. Patent 5,087,243, 1992.
98. Labhasetwar, V., Underwood, T., Schwendeman, S. P., and Levy, R. J., Iontophoresis for modulation of cardiac drug delivery in dogs, Proc. Natl. Acad. Sci. U.S.A., 92(7), 2612-2616, 1995.
99. Schwendeman, S. P., Labhasetwar, V., and Levy, R. J., Model features of a cardiac iontophoretic drug delivery implant, Pharm. Res., 12(5), 790-795, 1995.
100. Templer, J. and Renner, G. J., Injuries of the external ear, Otolaryngol. Clin. North Am., 23(5), 1003-1018, 1990.
101. Chambers, H. F. and Sande, M. A., In Goodman and Gilman's: The Pharmacological Basis of Therapeutics, Hardman, J. and Limbird, L., Eds., 9 Ed, McGraw-Hill, New York, NY, 1996, 1029-1076.
102. Macaluso, R. A. and Kennedy, T. L., Antibiotic iontophoresis in the treatment of burn perichondritis of the rabbit ear, Otolaryngol. Head Neck Surg., 100(6), 568-572, 1989.
103. Kaweski, S., Baldwin, R. C., Wong, R. K., and Manders, E. K., Diffusion vs. iontophoresis in the transport of gentamicin in the burned rabbit ear model, Plast. Reconstr. Surg., 92(7), 1342-1349; discussion 1350-1351, 1993.
104. Desai, M. H., Rutan, R. L., Heggers, J. P., Alvarado, M. I., McElroy, K., and Henrdon, D. N., The role of gentamicin iontophoresis in the treatment of burned ears, J. Burn Care Rehabil., 12(6), 521-524, 1991.
105. LaForest, N. T. and Cofrancesco, C., Antibiotic iontophoresis in the treatment of ear chondritis, Phys. Ther., 58(1), 32-34, 1978.
106. Greminger, R. F., Elliott, R. A., Jr., and Rapperport, A., Antibiotic iontophoresis for the management of burned ear chondritis, Plast. Reconstr. Surg., 66(3), 356-360, 1980.
107. Rigano, W., Yanik, M., Barone, F. A., Baibak, G., and Cislo, C., Antibiotic iontophoresis in the management of burned ears, J. Burn Care Rehabil., 13(4), 407-409, 1992.
108. Kloth, L. C. and McCulloch, J. M., Promotion of wound healing with electrical stimulation., Adv. Wound Care, 9(5), 42-45, 1996.
109. Catterall, W. and Mackie, K., In Goodman and Gilman's: The Pharmacological Basis of Therapeutics, Hardman, J. and Limbird, L., Eds., 9 Ed, McGraw-Hill, New York, NY, 1996, 331-347.
110. Lidocaine, In American Hospital Formulary Services: Drug Information, American Society of Health-System Parmacists, Inc., 1996, 2361-2362.
111. Riviere, J. E., Monteiro, Riviere, N. A., and Inman, A. O., Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs, Pharm. Res., 9(2), 211-214, 1992.
112. Physician's Desk Reference (50 Ed), Medical Economics Co., Montvale, NJ, 545, 567, 570, 959, 1639, 1996.
113. Russo, J., Jr., Lipman, A. G., Comstock, T. J., Page, B. C., and Stephen, R. L., Lidocaine anesthesia: comparison of iontophoresis, injection, and swabbing, Am. J. Hosp. Pharm., 37(6), 843-847, 1980.
114. Soliman, I. E., Broadman, L. M., Hannallah, R. S., and McGill, W. A., Comparison of the analgesic effects of EMLA (eutectic mixture of local anesthetics) to intradermal lidocaine infiltration prior to venous cannulation in unpremedicated children, Anesthesiology, 68(5), 804-806, 1988.
115. Zeltzer, L., Regalado, M., Nichter, L. S., Barton, D., Jennings, S., and Pitt, L., Iontophoresis vs. subcutaneous injection: a comparison of two methods of local anesthesia delivery in children, Pain, 44(1), 73-78, 1991.
116. Riviere, J. E., Sage, B., and Williams, P. L., Effects of vasoactive drugs on transdermal lidocaine iontophoresis, J. Pharm. Sci., 80(7), 615-620, 1991.
117. Singh, P. and Roberts, M. S., Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures, J. Pharm. Sci., 82(2), 127-131, 1993.
118. Ernst, A. A., Pomerantz, J., Nick, T. G., Limbaugh, J., and Landry, M., Lidocaine via iontophoresis in laceration repair: a preliminary safety study, Am. J. Emerg. Med., 13(1), 17-20, 1995.
119. Petelenz, T., Axenti, I., Petelenz, T. J., Iwinski, J., and Dubel, S., Mini set for iontophoresis for topical analgesia before injection, Int. J. Clin. Pharmacol. Ther. Toxicol., 22(3), 152-5, 1984.
120. Bezzant, J. L., Stephen, R. L., Petelenz, T. J., and Jacobsen, S. C., Painless cauterization of spider veins with the use of iontophoretic local anesthesia, J. Am. Acad. Dermatol., 19(5 Pt 1), 869-875, 1988.
121. Kennard, C. D. and Whitaker, D. C., Iontophoresis of lidocaine for anesthesia during pulsed dye laser treatment of port-wine stains, J. Dermatol. Surg. Oncol., 18(4), 287-294, 1992.
122. Irsfeld, S., Klement, W., and Lipfert, P., Dermal anaesthesia: comparison of EMLA cream with iontophoretic local anaesthesia., Br. J. Anaesth., 71(3), 375-378, 1993.
123. Buckley, M. M. and Benfield, P., Eutectic lidocaine/prilocaine cream. A review of the topical anaesthetic/analgesic efficacy of a eutectic mixture of local anaesthetics (EMLA), Drugs, 46(1), 126-151, 1993.
124. Greenbaum, S. S. and Bernstein, E. F., Comparison of iontophoresis of lidocaine with a eutectic mixture of lidocaine and prilocaine (EMLA) for topically administered local anesthesia, J. Dermatol. Surg. Oncol., 20(9), 579-583, 1994.
125. Schatz, M. and Fung, D., Anaphylactoid and anaphylactic reactions due to anesthetic agents, Clin. Rev. Allergy, 4, 215-221, 1986.
126. Chandler, M. J., Grammer, L. C., and Patterson, R., Provocative challenge with local anesthetics in patients with a prior history of reaction., J. Allergy Clin. Immunol., 79(6), 883-886, 1987.
127. Maloney, J. M., Bezzant, J. L., Stephen, R. L., and Petelenz, T. J., Iontophoretic administration of lidocaine anesthesia in office practice: an appraisal, J. Dermatol. Surg. Oncol., 18(11), 937-940, 1992.
128. Oshima, T., Kashiki, K., Toyooka, H., Masuda, A., and Amaha, K., Cutaneous iontophoretic application of condensed lidocaine, Can. J. Anaesth., 41(8), 677-679, 1994.
129. Schimmer, B. and Parker, K., In Goodman and Gilman's: The Pharmacological Basis of Therapeutics, Hardman, J. and Limbird, L., Eds., 9 ed., McGraw-Hill, New York, NY, 1996, 1459-1485.
130. Insel, P., In Goodman and Gilman's: The Pharmacological Basis of Therapeutics, Hardman, J. and Limbird, L., Eds., 9th ed., McGraw-Hill, New York, NY, 1996, 617-658.
131. Ketoprofen, In American Hospital Formulary Services: Drug Information, American Society of Health-System Parmacists, Inc., 1996, 1416-1422.
132. Kamath, S. S. and Gangarosa, L. P., Sr., Electrophoretic evaluation of the mobility of drugs suitable for iontophoresis, Meth. Find. Exp. Clin. Pharmacol., 17(4), 227-232, 1995.
133. Dexamethasone, In American Hospital Formulary Services: Drug Information, American Society of Health-System Parmacists, Inc., 1996, 2230-2232.
134. Petelenz, T. J., Buttke, J. A., Bonds, C., Lloyd, L. B., Beck, J. E., Stephen, R. L., Jacobsen, S. C., and Rodriguez, P., Iontophoresis of dexamethasone: laboratory studies, J. Control Release, 20, 55-66, 1992.
135. James, M. P., Graham, R. M., and English, J., Percutaneous iontophoresis of prednisolone - a pharmacokinetic study, Clin. Exp. Dermatol., 11(1), 54-61, 1986.
136. Wang, Y., Allen, L. V., Jr., Li, L. C., and Tu, Y. H., Iontophoresis of hydrocortisone across hairless mouse skin: investigation of skin alteration., J. Pharm. Sci., 82(11), 1140-1144, 1993.
137. Seth, S. C., Allen, L. V., and Pinnamaraju, P., Stability of hydrocortisone salts during iontophoresis, Int. J. Pharm., 106, 7-14, 1994.
138. Chantraine, A., Ludy, J. P., and Berger, D., Is cortisone iontophoresis possible? Arch. Phys. Med. Rehabil., 67(1), 38-40, 1986.
139. Hasson, S. M., Wible, C. L., Reich, M., Barnes, W. S., and Williams, J. H., Dexamethasone iontophoresis: effect on delayed muscle soreness and muscle function, Can. J. Sport Sci., 17(1), 8-13, 1992.
140. Harris, P. R., Iontophoresis: clinical research in musculoskeletal inflammatory conditions, J. Orthop. Sports Phys. Ther., 4(2), 109-112 , 1982.
141. Bertolucci, L. E., Introduction of antiinflammatory drugs by iontophoresis: double blind study, J. Orthop. Sports Phys. Ther., 4(2), 103-108, 1982.
142. Hasson, S. H., Henderson, G. H., Daniels, J. C., and Schieb, D. A., Exercise training and dexamethasone iontophoresis in rheumatoid arthritis: a case study, Physiother. Can., 43(2), 11-14, 1991.
143. Li, L. C., Scudds, R. A., Heck, C. S., and Harth, M., The efficacy of dexamethasone iontophoresis for the treatment of rheumatoid arthritic knees: a pilot study, Arthritis Care Res., 9(2), 126-132, 1996.
144. Banta, C. A., A prospective, nonrandomized study of iontophoresis, wrist splinting, and antiinflammatory medication in the treatment of early-mild carpal tunnel syndrome, J. Occup. Med., 36(2), 166-168, 1994.
145. Pellecchia, G. L., Hamel, H., and Behnke, P., Treatment of infrapatellar tendinitis: a combination of modalities and transverse friction massage vs. iontophoresis, J. Sport Rehabil., 3(2), 135-145, 1994.
146. Gudeman, S. D., Eisele, S. A., Heidt, R. S., Jr., Colosimo, A. J., and Stroupe, A. L., Treatment of plantar fasciitis by iontophoresis of 0.4% dexamethasone: a randomized, double-blind, placebocontrolled study, Am. J. Sports Med., 25(3), 312-316, 1997.
147. Reid, K. I., Dionne, R. A., Sicard Rosenbaum, L., Lord, D., and Dubner, R. A., Evaluation of iontophoretically applied dexamethasone for painful pathologic temporomandibular joints, Oral. Surg. Oral. Med. Oral Pathol., 77(6), 605-609, 1994.
148. Pratzel, H., Dittrich, P., and Kukovetz, W., Spontaneous and forced cutaneous absorption of indomethacin in pigs and humans, J. Rheumatol., 13(6), 1122-1125, 1986.
149. Panus, P. C., Campbell, J., Kulkarni, B., Ravis, W. A., and Banga, A. K., Effect of iontophoretic current and application time on transdermal delivery of ketoprofen in man, Pharm. Sci., 2, 461-469, 1996.
150. Panus, P. C., Campbell, J., Kulkarni, S. B., Herrick, R. T., and Banga, A. K., Transdermal iontophoretic delivery of ketoprofen through human cadaver skin and in humans, J. Control. Rel., 44(Feb. 17), 113-121, 1997.
151. Varghese, E. and Khar, R. K., Enhanced skin permeation of diclofenac by ionitophoresis: in vitro and in vivo studies, J. Control. Rel., 38, 21-27, 1996.
152. Schrier, D. J., Moniot, S., Gluckman, M. I., and Gilbertsen, R. B., The topical anti-inflammatory effects of a topical preparation of meclofenamic acid on carrageenan-induced footpad swelling in mice, J. Pharm. Pharmacol., 39(1), 57-59, 1987.
153. Brooks, R. R., Bonk, K. R., Decker, G. E., and Miller, K. E., Anti-inflammatory activity of orpanoxin administered orally and topically to rodents, Agents Actions, 16(5), 369-376, 1985.
154. Nolan, J. C., Wagner, L. E., Gathright, C. E., Stephens, D. J., and Sancilio, L. F., The topical antiinflammatory and analgesic properties of bromfenac in rodents, Agents Actions, 25(1-2), 77-85, 1988.
155. Chi, S. C. and Jun, H. W., Anti-inflammatory activity of ketoprofen gel on carrageenan-induced paw edema in rats, J. Pharm. Sci., 79(11), 974-977, 1990.
156. Famaey, J. P., Broux, G., Cleppe, D., Deroulez, A., Duckerts, F., Evrard, F., Goethals, L., Vanhecke, J., Verbruggen, L., and Tyberghein, J. M., Ionisation with Voltaren. A multi-center trial, J. Belge. Med. Phys. Rehabil., 5(2), 55-60, 1982.
157. Vecchini, L. and Grossi, E., Ionization with diclofenac sodium in rheumatic disorders: a double-blind placebocontrolled trial, J. Int. Med. Res., 12(6), 346-350, 1984.
158. Grossi, E., Monza, G. C., Pollavini, S., and Bona, L., NSAID ionisation in the management of soft-tissue rheumatism: role played by the drug, electrical stimulation and suggestion, Clin. Exp. Rheumatol., 4(3), 265-267, 1986.
159. Garagiola, U., Dacatra, U., Braconaro, F., Porretti, E., Pisetti, A., and Azzolini, V., Iontophoretic administration of pirprofen or lysine soluble aspirin in the treatment of rheumatic diseases, Clin. Ther., 10(5), 553-558, 1988.
160. Saggini, R., Zoppi, M., Vecchiet, F., Gatteschi, L., Obletter, G., and Giamberardino, M. A., Comparison of electromotive drug administration with ketorolac or with placebo in patients with pain from rheumatic disease: a double-masked study, Clin. Ther., 18(6), 1169-1174, 1996.
161. Treco, D. A. and Selden, R. F., Nonviral gene therapy, Mol. Med. Today, 1, 314-321, 1995.
162. Weaver, J. C., Electroporation theory - concepts and mechanisms, in Electroporation Protocols for Microorganisms, Nickoloff, J. A., Ed., Humana Press, Totowa, NJ, 1995, 1-26.
163. Tomov, T. C., Quantitative dependence of electroporation on the pulse parameters, Bioelectrochem. Bioenerg., 37, 101-107, 1995.
164. Weaver, J. C., Electroporation: A general phenomenon for manipulating cells and tissues, J. Cell. Biochem., 51, 426-435, 1993.
165. Inada, H., Ghanem, A. H., and Higuchi, W. I., Studies on the effects of applied voltage and duration on human epidermal membrane alteration/recovery and the resultant effects upon iontophoresis, Pharm. Res., 11, 687-697, 1994.
166. Weaver, J. C. and Chizmadzhev, Y., Electroporation, in Biological Effects of Electromagnetic Fields, vol. 2, Polte, C. and Postow, E., Ed., Boca Raton, FL, 1997, 247-274.
167. Mitragotri, S., Blankschtein, D., and Langer, R., Ultrasound-mediated transdermal protein delivery, Science, 269(5225), 850-853, 1995.
168. Byl, N. N., McKenzie, A., Halliday, B., Wong, T., and O'Connell, J., The effects of phonophoresis with corticosteroids: a controlled pilot study, J. Orthop. Sports Phys. Ther., 18(5), 590-600, 1993.
169. Bare, A. C., McAnaw, M. B., Pritchard, A. E., Struebing, J. G., Smutok, M. A., Christie, D. S., Domenech, M. A., Bare, M. A., Bloodworth, M. L., and Seal, L. A., Phonophoretic delivery of 10% hydrocortisone through the epidermis of humans as determined by serum cortisol concentrations, Phys. Ther., 76(7), 738-745, 1996.
170. Riviere, J. E., Monteiro-Riviere, N. A., Rogers, R. A., Bommannan, D., Potts, R. O., and Et, A. L., Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin toxicology, J. Control. Rel., 36, 229-233, 1995.
171. Ueda, H., Ogihara, M., Sugibayashi, K., and Morimoto, Y., Change in the electrochemical properties of skin and the lipid packing in stratum corneum by ultrasonic irradiation, Int. J. Pharm., 137, 217-224, 1996.
172. Kost, J., Pliquett, U., Mitragotri, S., Yamamoto, A., Langer, R., and Weaver, J., Synergistic effect of electric field and ultrasound on transdermal transport, Pharm. Res., 13(4), 633-638, 1996.
173. Smith, K. J., Konzelman, J. L., Lombardo, F. A., Skelton, H. G., III, Holland, T. T., Yeager, J., Wagner, K. F., Oster, C. N., and Chung, R., Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients, Arch. Dermatol., 128(10), 1365-1370, 1992.
174. Layman, P. R., Argyras, E., and Glynn, C. J., Iontophoresis of vincristine vs. saline in post-herpetic neuralgia. A controlled trial, Pain, 25(2), 165-170, 1986.
175. Chang, B. K., Guthrie, T. H., Hayakawa, K., and Gangarosa, L. P., A pilot study of iontophoretic cisplatin chemotherapy of basal and squamous cell carcinomas of the skin, Arch. Dermatol, 129, 425-427, 1993.
176. Ashburn, M. A., Stephen, R. L., Ackerman, E., Petelenz, T. J., Hare, B., Pace, N. L., and Hofman, A. A., Iontophoretic delivery of morphine for postoperative analgesia., J. Pain Symptom Manage., 7(1), 27-33, 1992.
177. Ashburn, M. A., Streisand, J., Zhang, J., Love, G., Rowin, M., Niu, S., Kievit, J. K., Kroep, J. R., and Mertens, M. J., The iontophoresis of fentanyl citrate in humans, Anesthesiology, 82(5), 1146-1153, 1995.
178. Arvidsson, S. B., Ekroth, R. H., Hansby, A. M., Lindholm, A. H., and William Olsson, G., Painless venipuncture. A clinical trial of iontophoresis of lidocaine for venipuncture in blood donors, Acta Anaesthesiol. Scand., 28(2), 209-210, 1984.